Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in Co-occurring Bipolar and Cannabis Use Disorders
NCT05064319Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2022
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in bipolar disorder (BD), cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Feb 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
bipolar disorder (BD)cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT05064319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05064319.